Lucy Scientific Discovery Inc. Appoints Richard Nanula as Chief Executive Officer
Lucy Scientific Discovery Inc. has appointed Richard Nanula, current Executive Chairman, as the new Chief Executive Officer, effective immediately. Nanula has extensive senior leadership experience from major companies, including The Walt Disney Company and Amgen, and has overseen over $50 billion of M&A and financing transactions. He will retain his Chairman role and succeed Chris McElvany, who will transition into a consulting role.
Lucy Scientific Discovery Inc. is a leader in the psychotropic industry, with a focus on pioneering innovative therapies for patients in need. The company holds a Controlled Drugs and Substances Dealer's License granted by Health Canada's Office of Controlled Substances, allowing it to develop, sell, deliver, and manufacture pharmaceutical-grade active pharmaceutical ingredients (APIs) used in controlled substances.
The appointment of Nanula marks a significant step in Lucy's growth and commitment to advancing the field of psychotropic drug development. As CEO, Nanula plans to leverage the company's position to address the unmet needs of the global wellness community and create value for shareholders.
Key Takeaways:
- Richard Nanula has been appointed as the new Chief Executive Officer of Lucy Scientific Discovery Inc., effective immediately.
- Nanula brings decades of senior leadership experience from major companies, including The Walt Disney Company and Amgen, with over $50 billion of M&A and financing transactions under his belt.
- He will retain his Chairman role while succeeding Chris McElvany, who will transition into a consulting role.
- Lucy Scientific Discovery Inc. holds a Controlled Drugs and Substances Dealer's License granted by Health Canada's Office of Controlled Substances.
- The company is committed to advancing the field of psychotropic drug development and addressing the unmet needs of the global wellness community.
Statistics:
- $50 billion: The amount of M&A and financing transactions overseen by Richard Nanula during his career.
- 20+ years: The duration of Richard Nanula's senior leadership experience from major companies, including The Walt Disney Company and Amgen.
- 1: The number of time the company has held a Controlled Drugs and Substances Dealer's License granted by Health Canada's Office of Controlled Substances.
Sources:
- "Lucy Scientific Discovery Inc. Appoints Richard Nanula as Chief Executive Officer," Globe Newswire, July 13, 2023.
- "Press Release: Lucy Scientific Discovery Inc. and Announcement of New CEO," Lucy Scientific Discovery Inc. website, July 13, 2023.